WO2021011885A1 - Claudin18 antibodies and methods of treating cancer - Google Patents

International application published with international search report

WO2020025792A1 - Antibody constructs for cldn18.2 and cd3 - Google Patents

The targeting of Claudin 6 in Antibody and CAR-T cell therapies

WO2021238831A1 - Anti-cldn18.2 antibodies and diagnostic uses thereof - Google Patents

WO2022063272A1 - Novel anti-claudin18 antibodies - Google Patents

Transcriptional activation of the human claudin-18 gene promoter through two AP-1 motifs in PMA-stimulated MKN45 gastric cancer cells

WO2021024020A1 - Combination therapy involving antibodies against claudin 18.2 and immune checkpoint inhibitors for treatment of cancer - Google Patents

PDF) Claudin18.2 is a novel molecular biomarker for tumor-targeted immunotherapy

WO2019174617A1 - Anti-claudin 18.2 antibodies - Google Patents

WO2022063272A1 - Novel anti-claudin18 antibodies - Google Patents

Targeted Therapy of Cancer with Radiolabeled Antibodies

WO2021032157A1 - Novel anti-cldn18.2 antibodies - Google Patents